Drug intelligence / Profile preview

thrombin

Development stage
Approved
Lead developer
Bristol Myers Squibb
Modality
Therapeutic Enzymes → Recombinant Proteins and Enzymes
Administration
Topical
01

Overview

Thrombin is a serine protease and a key enzyme in the blood coagulation cascade. It is produced from prothrombin (coagulation factor II) and functions by converting soluble fibrinogen into insoluble fibrin strands to form blood clots. Thrombin also activates several other coagulation factors (V, VIII, XI, XIII), promotes platelet activation and aggregation via protease-activated receptors on platelets, and has both procoagulant and anticoagulant roles depending on its interactions with cofactors such as thrombomodulin. Medically used forms of thrombin include those derived from human plasma (human thrombin), bovine sources (bovine thrombin), or produced recombinantly (recombinant human thrombin). These products are primarily used topically during surgical procedures to control bleeding when standard techniques are ineffective or impractical[1][2][3][4][8].

Brand names
Thrombin-JMIEVITHROMRecothrom
Other names
coagulation factor IIahuman thrombinbovine thrombinrecombinant human thrombin
02

Targets

PAR4 (Protease-activated receptor 4)PAR-1 (Protease-activated receptor 1)F11 (Coagulation Factor XI)Coagulation Factor XIIIPAR2 (Protease-activated receptor 2)F8 (Coagulation Factor VIIIa)F5 (Coagulation Factor V)

Beyond the preview

Go deeper on thrombin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on thrombin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call